JP2001039976A5 - - Google Patents

Download PDF

Info

Publication number
JP2001039976A5
JP2001039976A5 JP2000151138A JP2000151138A JP2001039976A5 JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5 JP 2000151138 A JP2000151138 A JP 2000151138A JP 2000151138 A JP2000151138 A JP 2000151138A JP 2001039976 A5 JP2001039976 A5 JP 2001039976A5
Authority
JP
Japan
Prior art keywords
compound according
active ingredient
preventing
agent
prophylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2000151138A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001039976A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000151138A priority Critical patent/JP2001039976A/ja
Priority claimed from JP2000151138A external-priority patent/JP2001039976A/ja
Publication of JP2001039976A publication Critical patent/JP2001039976A/ja
Publication of JP2001039976A5 publication Critical patent/JP2001039976A5/ja
Ceased legal-status Critical Current

Links

JP2000151138A 1999-05-24 2000-05-23 縮合複素環化合物の塩酸塩 Ceased JP2001039976A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000151138A JP2001039976A (ja) 1999-05-24 2000-05-23 縮合複素環化合物の塩酸塩

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11-143513 1999-05-24
JP14351399 1999-05-24
JP2000151138A JP2001039976A (ja) 1999-05-24 2000-05-23 縮合複素環化合物の塩酸塩

Publications (2)

Publication Number Publication Date
JP2001039976A JP2001039976A (ja) 2001-02-13
JP2001039976A5 true JP2001039976A5 (https=) 2007-07-12

Family

ID=26475217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000151138A Ceased JP2001039976A (ja) 1999-05-24 2000-05-23 縮合複素環化合物の塩酸塩

Country Status (1)

Country Link
JP (1) JP2001039976A (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1870997B (zh) 2003-10-24 2011-05-04 参天制药株式会社 角膜结膜病变的治疗剂
US7348329B2 (en) 2003-10-29 2008-03-25 Santen Pharmaceutical Co., Ltd. Therapeutic agent for keratoconjunctival disorder
JP2006225382A (ja) * 2005-01-24 2006-08-31 Sankyo Co Ltd チアゾリジンジオン化合物の製造方法及びその製造中間体
TW200637856A (en) 2005-01-24 2006-11-01 Sankyo Co Process for producing thiazolidinedion compound and intermediate thereof
EP1964575B1 (en) 2005-11-28 2015-09-23 Senju Pharmaceutical Co., Ltd. Pharmaceutical comprising ppar agonist
JP2008044932A (ja) * 2006-07-21 2008-02-28 Daiichi Sankyo Co Ltd チアゾリジンジオン化合物を含有する組成物
TW200816995A (en) * 2006-08-31 2008-04-16 Daiichi Sankyo Co Ltd Pharmaceutical composition containing insulin sensitizers
US8802705B2 (en) 2007-05-21 2014-08-12 Senju Pharmaceutical Co., Ltd. Pharmaceutical containing PPAR delta agonist

Similar Documents

Publication Publication Date Title
AU2002244860B2 (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV
JP2008007519A5 (https=)
RU2001131722A (ru) 5-[4-(6-Метокси-1-метил-1Н-бензимидазол-2-илметокси)бензил]-тиазолидин-2,4 -ди он гидрохлорид, обладающий гипогликемической активностью
JP2003501361A5 (https=)
AU2002244860A1 (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV
Markham Remogliflozin etabonate: first global approval
TWI255817B (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
JP2010530431A5 (https=)
JP2006502187A5 (https=)
JP2007519649A5 (https=)
JP2004522714A5 (https=)
MXPA03006217A (es) Sistema de administracion espaciada de farmacos.
JP2007533733A5 (https=)
JP2005526696A5 (https=)
JP2004508399A5 (https=)
JP2001039976A5 (https=)
EP1612208A3 (en) N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
US20160287549A1 (en) Novel methods for treating neurodegenerative diseases
JP2002508372A5 (https=)
WO2005039578A3 (en) Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
JP2002532416A5 (ja) 脳のグルコース利用を増進させる医薬組成物
BR112019026029A2 (pt) Formulações farmacêuticas orais de remogliflozina
JP2002537246A5 (https=)
EP1541171A4 (en) MEANS FOR THE TREATMENT OF DIABETES MELLITUS
JP2007538102A5 (https=)